Technical Analysis for DNAY - Codex DNA, Inc.

Grade Last Price % Change Price Change
F 7.05 2.03% 0.14
DNAY closed up 7.8 percent on Tuesday, December 7, 2021, on 82 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Up
Historical DNAY trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 2.03%
Bullish Engulfing Bullish 2.03%
Wide Bands Range Expansion 2.03%
Oversold Stochastic Weakness 2.03%
New 52 Week Closing Low Bearish 9.98%
Narrow Range Bar Range Contraction 9.98%
NR7 Range Contraction 9.98%
Doji - Bullish? Reversal 9.98%
New 52 Week Low Weakness 9.98%
Stochastic Reached Oversold Weakness 9.98%
Older End-of-Day Signals for DNAY ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 37 minutes ago
Rose Above Previous Day's High 37 minutes ago
Up 2% 37 minutes ago
Up 1% 37 minutes ago
Up 10% about 21 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Codex DNA, Inc. Description

Codex DNA is a synthetic biology company focused on enabling researchers to rapidly, accurately and reproducibly build or “write” high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets. Codex DNA’s synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, as well as the significant limitations of existing solutions that prevent the rapid building of virtually error-free DNA and mRNA at a useable scale. A key part of Codex DNA’s solution is the BioXp™ system, an end-to-end automated workstation that fits on the benchtop and is broadly accessible due to its ease-of-use and hands-free automation. Codex DNA believes the BioXp™ system can democratize synthetic biology by simplifying the process of building DNA and mRNA, thereby accelerating the discovery, development and production of novel high-value products, including antibody-based biologics, mRNA-based vaccines and therapeutics and precision medicines.


Sector: Healthcare
Industry: Medical Devices
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Emerging Technologies Molecular Biology RNA Molecular Genetics Synthetic Biology Messenger RNA

Is DNAY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 25.7
52 Week Low 6.2162
Average Volume 71,900
200-Day Moving Average 0.00
50-Day Moving Average 9.20
20-Day Moving Average 7.38
10-Day Moving Average 6.75
Average True Range 0.63
ADX 32.13
+DI 18.70
-DI 26.03
Chandelier Exit (Long, 3 ATRs) 9.00
Chandelier Exit (Short, 3 ATRs) 8.12
Upper Bollinger Bands 8.96
Lower Bollinger Band 5.79
Percent B (%b) 0.35
BandWidth 42.98
MACD Line -0.79
MACD Signal Line -0.84
MACD Histogram 0.0519
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.97
Resistance 3 (R3) 7.91 7.50 7.79
Resistance 2 (R2) 7.50 7.23 7.53 7.73
Resistance 1 (R1) 7.21 7.07 7.36 7.26 7.67
Pivot Point 6.80 6.80 6.87 6.83 6.80
Support 1 (S1) 6.50 6.53 6.65 6.56 6.15
Support 2 (S2) 6.09 6.36 6.12 6.09
Support 3 (S3) 5.80 6.09 6.03
Support 4 (S4) 5.85